Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Valent

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of the American College of Cardiology|June 25, 2016
Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart FailureBrett W Sperry, Asad Ikram, Rory Hachamovitch, et al.
Leukemia & Lymphoma|July 6, 2019
Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world populationRajshekhar Chakraborty, Lisa Rybicki, Jacqulyn Tomer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2024
Effects of early palliative care integration on patients with newly diagnosed multiple myelomaRenato V Samala, Daniel P Nurse, Xiaoying Chen, et al.
Circulation. Heart Failure|January 25, 2023
Hemodynamic Profiling and Prognosis in Cardiac AmyloidosisPieter Martens, Sanjeeb Bhattacharya, Joshua Longinow, et al.
Journal of Cardiac Failure|July 26, 2022
Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and OutcomesPieter Martens, Mazen Hanna, Jason Valent, et al.
Blood|June 30, 2022
Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM scoreRajshekhar Chakraborty, Lisa Rybicki, Wei Wei, et al.
Cleveland Clinic Journal of Medicine|January 10, 2019
Monoclonal gammopathy of undetermined significance: A primary care guideJack Khouri, Christy Samaras, Jason Valent, et al.
Cleveland Clinic Journal of Medicine|January 10, 2019
Progress in diagnosing and managing cardiac amyloidosisMazen Hanna, Chetan Huded, E Rene Rodriguez, et al.
JCO Oncology Practice|February 14, 2024
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care DisparitiesHamlet Gasoyan, Faiz Anwer, Nicholas J Casacchia, et al.
British Journal of Haematology|February 4, 2020
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myelomaDiana Basali, Rajshekhar Chakraborty, Lisa Rybicki, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of the American College of Cardiology|June 25, 2016
Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart FailureBrett W Sperry, Asad Ikram, Rory Hachamovitch, et al.
Leukemia & Lymphoma|July 6, 2019
Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world populationRajshekhar Chakraborty, Lisa Rybicki, Jacqulyn Tomer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2024
Effects of early palliative care integration on patients with newly diagnosed multiple myelomaRenato V Samala, Daniel P Nurse, Xiaoying Chen, et al.
Circulation. Heart Failure|January 25, 2023
Hemodynamic Profiling and Prognosis in Cardiac AmyloidosisPieter Martens, Sanjeeb Bhattacharya, Joshua Longinow, et al.
Journal of Cardiac Failure|July 26, 2022
Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and OutcomesPieter Martens, Mazen Hanna, Jason Valent, et al.
Blood|June 30, 2022
Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM scoreRajshekhar Chakraborty, Lisa Rybicki, Wei Wei, et al.
Cleveland Clinic Journal of Medicine|January 10, 2019
Monoclonal gammopathy of undetermined significance: A primary care guideJack Khouri, Christy Samaras, Jason Valent, et al.
Cleveland Clinic Journal of Medicine|January 10, 2019
Progress in diagnosing and managing cardiac amyloidosisMazen Hanna, Chetan Huded, E Rene Rodriguez, et al.
JCO Oncology Practice|February 14, 2024
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care DisparitiesHamlet Gasoyan, Faiz Anwer, Nicholas J Casacchia, et al.
British Journal of Haematology|February 4, 2020
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myelomaDiana Basali, Rajshekhar Chakraborty, Lisa Rybicki, et al.
Pageof 9